Evaluating artificial intelligence models for rupture risk prediction in unruptured intracranial aneurysms: a focus on vessel geometry and hemodynamic insights.
Journal:
Neurosurgical review
Published Date:
Jul 2, 2025
Abstract
The estimation of rupture risk in Unruptured Intracranial Aneurysm (UIA) constitutes a major area of clinical interest due to the significant morbidity and mortality rates associated with aneurysm rupture. Classic clinical models based on factors such as size and location have demonstrated limited predictive accuracy, with small aneurysms being capable of rupture and larger ones remaining stable. Recent advances in Artificial Intelligence (AI) now allow the development of more sophisticated models that integrate both geometric and hemodynamic variables, including wall shear stress (WSS) and blood flow dynamics. While previous studies have examined these factors separately, our review specifically focuses on how they are combined within AI-based predictive models for unruptured intracranial aneurysms (UIAs). This integrated approach offers a more comprehensive and patient-specific risk assessment, going beyond traditional size-based methods. A wide array of machine learning (ML) and deep learning (DL) using SVMs (Support Vector Machine) and CNNs (Convolutional Neural Network) has demonstrated much better predictive accuracy than those attained by classical methods. Minimum necessary hemodynamic parameters including WSS and oscillatory shear index (OSI) were identified as critical indicators of rupture. Moreover, the review emphasized how CFD (Computational Fluid Dynamics) merged with AI in simulating patient-specific hemodynamics, outstanding progress having been achieved in the realm of risk assessment. Currently, there are promising developments in AI models for clinical practice, but large and good-quality datasets, along with interpretation of model predictions, remain challenges. More research would further refine these models toward improvement, with increased utility in a clinical setup to better aim at patient-specific risk assessment and optimization of treatment strategies for UIAs.
